Risk perceptions of low nicotine cigarettes and alternative nicotine products across priority smoking populations

Rachel L. Denlinger‐apte; Lauren R. Pacek; Jennifer Cornacchione Ross; Maansi Bansal‐travers; Eric C. Donny; Dorothy K. Hatsukami; Dana Mowls Carroll

doi:10.3390/ijerph18105311

Risk perceptions of low nicotine cigarettes and alternative nicotine products across priority smoking populations

Rachel L. Denlinger‐apte, Lauren R. Pacek, Jennifer Cornacchione Ross, Maansi Bansal‐travers, Eric C. Donny, Dorothy K. Hatsukami, Dana Mowls Carroll

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Background: As the U.S. Food and Drug Administration considers a low nicotine product standard for cigarettes, it is important to examine how people who smoke, especially individuals from priority populations disproportionately affected by smoking, perceive low nicotine content (LNC) cigarettes and their relative risk perceptions of alternative nicotine delivery system (ANDS) products, including e‐cigarettes and snus, and medicinal nicotine. Methods: Data are from Wave 4 (2016–2017) of the adult Population Assessment of Tobacco Use and Health (PATH) Study. We examined respondents’ absolute risk perceptions about nicotine, LNC cigarettes, ANDS products and medicinal nicotine; their relative risk perceptions of LNC cigarettes and ANDS products compared to conventional cigarettes; and their relative risk perceptions of medicinal nicotine compared to ANDS products. Results: The majority of respondents across priority smoking populations indicated snus, e‐cigarettes, and LNC cigarettes were ‘about the same’ level of harmfulness or addic-tiveness as conventional cigarettes. The majority of respondents indicated e‐cigarettes to be ‘about the same’ harmfulness as medicinal nicotine. Conclusions: Our study indicates that adults who smoke cigarettes generally have misperceptions about the harms of nicotine and the relative risks of ANDS products and such misperceptions exist regardless of their racial/ethnic identity, sexual orientation, and gender identity.

Original language	English (US)
Article number	5311
Journal	International journal of environmental research and public health
Volume	18
Issue number	10
DOIs	https://doi.org/10.3390/ijerph18105311
State	Published - May 2 2021

Bibliographical note

Funding Information:
Funding: This research was funded by the National Institute of Drug Abuse and the Food and Drug Administration’s Center for Tobacco Products, grant number U54DA031659 (to EC Donny and DK Hatsukami); the National Institute on Drug Abuse, grant number K01DA043413 (to LR Pacek); the National Institute on Minority Health and Health Disparities, grant number K01MD014795 (to DM Carroll); and the National Cancer Institute, grant number R03CA252767 (to RL Denlinger‐Apte). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration.

Funding Information:
This research was funded by the National Institute of Drug Abuse and the Food and Drug Administration?s Center for Tobacco Products, grant number U54DA031659 (to EC Donny and DK Hatsukami); the National Institute on Drug Abuse, grant number K01DA043413 (to LR Pacek); the National Institute on Minority Health and Health Disparities, grant number K01MD014795 (to DM Carroll); and the National Cancer Institute, grant number R03CA252767 (to RL Denlinger?Apte). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration.

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

Ethnicity
E‐cigarettes
LGBTQ+
Low nicotine cigarettes
Nicotine
Race
Risk perceptions
Snus

Publisher link

10.3390/ijerph18105311

Find It

Find It at U of M Libraries

Cite this

Denlinger‐apte, R. L., Pacek, L. R., Ross, J. C., Bansal‐travers, M., Donny, E. C., Hatsukami, D. K., & Carroll, D. M. (2021). Risk perceptions of low nicotine cigarettes and alternative nicotine products across priority smoking populations. International journal of environmental research and public health, 18(10), Article 5311. https://doi.org/10.3390/ijerph18105311

Risk perceptions of low nicotine cigarettes and alternative nicotine products across priority smoking populations. / Denlinger‐apte, Rachel L.; Pacek, Lauren R.; Ross, Jennifer Cornacchione et al.
In: International journal of environmental research and public health, Vol. 18, No. 10, 5311, 02.05.2021.

Research output: Contribution to journal › Article › peer-review

@article{87263737c7144b819463360a8dea5acd,

title = "Risk perceptions of low nicotine cigarettes and alternative nicotine products across priority smoking populations",

abstract = "Background: As the U.S. Food and Drug Administration considers a low nicotine product standard for cigarettes, it is important to examine how people who smoke, especially individuals from priority populations disproportionately affected by smoking, perceive low nicotine content (LNC) cigarettes and their relative risk perceptions of alternative nicotine delivery system (ANDS) products, including e‐cigarettes and snus, and medicinal nicotine. Methods: Data are from Wave 4 (2016–2017) of the adult Population Assessment of Tobacco Use and Health (PATH) Study. We examined respondents{\textquoteright} absolute risk perceptions about nicotine, LNC cigarettes, ANDS products and medicinal nicotine; their relative risk perceptions of LNC cigarettes and ANDS products compared to conventional cigarettes; and their relative risk perceptions of medicinal nicotine compared to ANDS products. Results: The majority of respondents across priority smoking populations indicated snus, e‐cigarettes, and LNC cigarettes were {\textquoteleft}about the same{\textquoteright} level of harmfulness or addic-tiveness as conventional cigarettes. The majority of respondents indicated e‐cigarettes to be {\textquoteleft}about the same{\textquoteright} harmfulness as medicinal nicotine. Conclusions: Our study indicates that adults who smoke cigarettes generally have misperceptions about the harms of nicotine and the relative risks of ANDS products and such misperceptions exist regardless of their racial/ethnic identity, sexual orientation, and gender identity.",

keywords = "Ethnicity, E‐cigarettes, LGBTQ+, Low nicotine cigarettes, Nicotine, Race, Risk perceptions, Snus",

author = "Denlinger‐apte, {Rachel L.} and Pacek, {Lauren R.} and Ross, {Jennifer Cornacchione} and Maansi Bansal‐travers and Donny, {Eric C.} and Hatsukami, {Dorothy K.} and Carroll, {Dana Mowls}",

note = "Funding Information: Funding: This research was funded by the National Institute of Drug Abuse and the Food and Drug Administration{\textquoteright}s Center for Tobacco Products, grant number U54DA031659 (to EC Donny and DK Hatsukami); the National Institute on Drug Abuse, grant number K01DA043413 (to LR Pacek); the National Institute on Minority Health and Health Disparities, grant number K01MD014795 (to DM Carroll); and the National Cancer Institute, grant number R03CA252767 (to RL Denlinger‐Apte). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration. Funding Information: This research was funded by the National Institute of Drug Abuse and the Food and Drug Administration?s Center for Tobacco Products, grant number U54DA031659 (to EC Donny and DK Hatsukami); the National Institute on Drug Abuse, grant number K01DA043413 (to LR Pacek); the National Institute on Minority Health and Health Disparities, grant number K01MD014795 (to DM Carroll); and the National Cancer Institute, grant number R03CA252767 (to RL Denlinger?Apte). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration. Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = may,

day = "2",

doi = "10.3390/ijerph18105311",

language = "English (US)",

volume = "18",

journal = "International journal of environmental research and public health",

issn = "1661-7827",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "10",

}

TY - JOUR

T1 - Risk perceptions of low nicotine cigarettes and alternative nicotine products across priority smoking populations

AU - Denlinger‐apte, Rachel L.

AU - Pacek, Lauren R.

AU - Ross, Jennifer Cornacchione

AU - Bansal‐travers, Maansi

AU - Donny, Eric C.

AU - Hatsukami, Dorothy K.

AU - Carroll, Dana Mowls

N1 - Funding Information: Funding: This research was funded by the National Institute of Drug Abuse and the Food and Drug Administration’s Center for Tobacco Products, grant number U54DA031659 (to EC Donny and DK Hatsukami); the National Institute on Drug Abuse, grant number K01DA043413 (to LR Pacek); the National Institute on Minority Health and Health Disparities, grant number K01MD014795 (to DM Carroll); and the National Cancer Institute, grant number R03CA252767 (to RL Denlinger‐Apte). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration. Funding Information: This research was funded by the National Institute of Drug Abuse and the Food and Drug Administration?s Center for Tobacco Products, grant number U54DA031659 (to EC Donny and DK Hatsukami); the National Institute on Drug Abuse, grant number K01DA043413 (to LR Pacek); the National Institute on Minority Health and Health Disparities, grant number K01MD014795 (to DM Carroll); and the National Cancer Institute, grant number R03CA252767 (to RL Denlinger?Apte). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021/5/2

Y1 - 2021/5/2

N2 - Background: As the U.S. Food and Drug Administration considers a low nicotine product standard for cigarettes, it is important to examine how people who smoke, especially individuals from priority populations disproportionately affected by smoking, perceive low nicotine content (LNC) cigarettes and their relative risk perceptions of alternative nicotine delivery system (ANDS) products, including e‐cigarettes and snus, and medicinal nicotine. Methods: Data are from Wave 4 (2016–2017) of the adult Population Assessment of Tobacco Use and Health (PATH) Study. We examined respondents’ absolute risk perceptions about nicotine, LNC cigarettes, ANDS products and medicinal nicotine; their relative risk perceptions of LNC cigarettes and ANDS products compared to conventional cigarettes; and their relative risk perceptions of medicinal nicotine compared to ANDS products. Results: The majority of respondents across priority smoking populations indicated snus, e‐cigarettes, and LNC cigarettes were ‘about the same’ level of harmfulness or addic-tiveness as conventional cigarettes. The majority of respondents indicated e‐cigarettes to be ‘about the same’ harmfulness as medicinal nicotine. Conclusions: Our study indicates that adults who smoke cigarettes generally have misperceptions about the harms of nicotine and the relative risks of ANDS products and such misperceptions exist regardless of their racial/ethnic identity, sexual orientation, and gender identity.

AB - Background: As the U.S. Food and Drug Administration considers a low nicotine product standard for cigarettes, it is important to examine how people who smoke, especially individuals from priority populations disproportionately affected by smoking, perceive low nicotine content (LNC) cigarettes and their relative risk perceptions of alternative nicotine delivery system (ANDS) products, including e‐cigarettes and snus, and medicinal nicotine. Methods: Data are from Wave 4 (2016–2017) of the adult Population Assessment of Tobacco Use and Health (PATH) Study. We examined respondents’ absolute risk perceptions about nicotine, LNC cigarettes, ANDS products and medicinal nicotine; their relative risk perceptions of LNC cigarettes and ANDS products compared to conventional cigarettes; and their relative risk perceptions of medicinal nicotine compared to ANDS products. Results: The majority of respondents across priority smoking populations indicated snus, e‐cigarettes, and LNC cigarettes were ‘about the same’ level of harmfulness or addic-tiveness as conventional cigarettes. The majority of respondents indicated e‐cigarettes to be ‘about the same’ harmfulness as medicinal nicotine. Conclusions: Our study indicates that adults who smoke cigarettes generally have misperceptions about the harms of nicotine and the relative risks of ANDS products and such misperceptions exist regardless of their racial/ethnic identity, sexual orientation, and gender identity.

KW - Ethnicity

KW - E‐cigarettes

KW - LGBTQ+

KW - Low nicotine cigarettes

KW - Nicotine

KW - Race

KW - Risk perceptions

KW - Snus

UR - http://www.scopus.com/inward/record.url?scp=85105780576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105780576&partnerID=8YFLogxK

U2 - 10.3390/ijerph18105311

DO - 10.3390/ijerph18105311

M3 - Article

C2 - 34067652

AN - SCOPUS:85105780576

SN - 1661-7827

VL - 18

JO - International journal of environmental research and public health

JF - International journal of environmental research and public health

IS - 10

M1 - 5311

ER -

Risk perceptions of low nicotine cigarettes and alternative nicotine products across priority smoking populations

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this